HB 1065 creates a new chapter in the Indiana Code establishing a “Cancer Clinical Trial Participation Program.” The bill authorizes an organization or entity to set up and administer a program that helps pay reasonable costs for Indiana residents who participate in cancer clinical trials. Covered expenses can include travel, lodging, parking, tolls, and other costs the administering organization approves. The bill also allows, but does not require, support payments for one designated companion such as a relative or friend who accompanies the participant to help with the trial.
The bill defines key terms used in the new chapter and ties them to existing Indiana Code definitions for “cancer clinical trial” and “participant.” It sets eligibility criteria for participants, including Indiana residency, income at or below 700% of the federal poverty level, residence in an underserved area as determined by the program administrator, and eligibility to take part in a cancer clinical trial. Organizations operating the program may accept gifts, grants, and donations from public or private sources to fund the assistance. The bill takes effect July 1, 2025.
Impact
HB 1065 adds a new chapter to Title 16 of the Indiana Code and makes related definitional changes so the new program fits within existing health-law terminology. It does not mandate a statewide state-run benefit; instead, it authorizes organizations or entities to create and administer voluntary cancer clinical trial assistance programs, subject to state and federal law. The practical effect is to create a legal framework for third-party or nonprofit-funded financial assistance that can reduce out-of-pocket barriers for eligible cancer patients, especially those in underserved areas.
Sentiment
The bill appears to have been broadly supported and noncontroversial in the legislature. It passed the House 95-0 and the Senate 49-0, indicating unanimous approval in both chambers. The available record shows no committee transcript debate, suggesting little visible opposition or extended controversy during the legislative process.
Contention
No major points of contention are reflected in the available materials. The main policy choices embedded in the bill are the income cap, the underserved-area eligibility requirement, and the fact that the program is permissive rather than mandatory. If there were concerns, they would likely have centered on how organizations define financial need, determine underserved areas, and decide what “other costs” qualify for reimbursement, but no specific objections are documented in the provided record.